Answers are grounded in this paper and cite their sources.
Genetic variations in angiogenesis-related genes lead to marked differences among patients in how well they respond to drugs that block new blood vessel formation. In a study of 57 individuals with metastatic colorectal cancer treated with bevacizumab plus chemotherapy, researchers tested 20 single nucleotide polymorphisms (SNPs) in 13 genes from the angiogenesis pathway to find markers that could forecast tumor shrinkage, progression-free survival (PFS), and overall survival (OS). DNA was obtai
No takes yet. Share an insight, caveat, or question.
Hye et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: